Dosaka-Akita H - Search Results

1

Cyclooxygenase-2 inhibitors for non-small-cell lung cancer: A phase II trial and literature review.

Yokouchi H, Kanazawa K, Ishida T, Oizumi S, Shinagawa N, Sukoh N, Harada M, Ogura S, Munakata M, Dosaka-Akita H, Isobe H, Nishimura M. Yokouchi H, et al. Mol Clin Oncol. 2014 Sep;2(5):744-750. doi: 10.3892/mco.2014.319. Epub 2014 Jun 19. Mol Clin Oncol. 2014. PMID: 25054040 Free PMC article.

2

Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer.

Harada M, Dosaka-Akita H, Miyamoto H, Kuzumaki N, Kawakami Y. Harada M, et al. Cancer. 1992 Jan 1;69(1):72-7. doi: 10.1002/1097-0142(19920101)69:1<72::aid-cncr2820690114>3.0.co;2-a. Cancer. 1992. PMID: 1309311

3

[Clinical significance of oncogene product expression in human lung cancer].

Dosaka-Akita H, Harada M, Miyamoto H, Kawakami Y. Dosaka-Akita H, et al. Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Aug;30(8):1441-7. Nihon Kyobu Shikkan Gakkai Zasshi. 1992. PMID: 1331597 Japanese.

4

Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer.

Fujino M, Dosaka-Akita H, Harada M, Hiroumi H, Kinoshita I, Akie K, Kawakami Y. Fujino M, et al. Cancer. 1995 Dec 15;76(12):2457-63. doi: 10.1002/1097-0142(19951215)76:12<2457::aid-cncr2820761209>3.0.co;2-x. Cancer. 1995. PMID: 8625071

5

"Web-like obstruction"--a sign of regional complete remission after concurrent chemoradiotherapy in small cell lung cancer.

Hanada T, Ogura S, Isobe H, Dosaka-Akita H, Yamazaki K, Watanabe N, Kawakami Y. Hanada T, et al. Intern Med. 1996 Sep;35(9):732-5. doi: 10.2169/internalmedicine.35.732. Intern Med. 1996. PMID: 8915702 Free article.

6

Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.

Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF. Dosaka-Akita H, et al. Cancer. 1997 Apr 1;79(7):1329-37. Cancer. 1997. PMID: 9083154

7

Ki-67 labeling indices in non-small cell lung cancer: comparison between image cytometry and flow cytometry.

Ishikuro A, Dosaka-Akita H, Kato M, Fujino M, Isobe H, Miyamoto H, Inoue K, Kawakami Y. Ishikuro A, et al. Cytometry. 1997 Aug 15;30(4):186-91. Cytometry. 1997. PMID: 9298837

8

Genetic factors in lung disease: atopy and bronchial asthma.

Kawakami Y, Yamaguchi E, Munakata M, Dosaka-Akita H, Furuya K. Kawakami Y, et al. Respirology. 1997 Mar;2(1):7-15. doi: 10.1111/j.1440-1843.1997.tb00050.x. Respirology. 1997. PMID: 9424407 Review.

9

Genetic factors in lung disease. Part II: Lung cancer and angiotensin converting enzyme gene.

Kawakami Y, Yamaguchi E, Munakata M, Dosaka-Akita H, Furuya K. Kawakami Y, et al. Respirology. 1997 Jun;2(2):81-90. doi: 10.1111/j.1440-1843.1997.tb00059.x. Respirology. 1997. PMID: 9441131 Review.

10

Bcl-2 expression in non-small cell lung cancers: higher frequency of expression in squamous cell carcinomas with earlier pT status.

Dosaka-Akita H, Katabami M, Hommura H, Fujioka Y, Katoh H, Kawakami Y. Dosaka-Akita H, et al. Oncology. 1999 Apr;56(3):259-64. doi: 10.1159/000011974. Oncology. 1999. PMID: 10202283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters